Oscar Health, Inc. (OSCR) Financials
Key financial figures for Oscar Health, Inc. (Q3 2026).
Oscar Health reported Q3 2026 earnings from operations of $178.0 million versus a $129.3 million loss a year earlier and raised its full-year 2026 earnings from operations outlook to $850 million to $950 million. Total revenue was $5.14 billion, up from $2.99 billion in Q3 2025 (about +72%, calculated), driven by rate increases and higher membership and including a $250 million benefit from updated risk adjustment estimates. The medical loss ratio was 84.0% versus 88.5% a year earlier, helped by pricing discipline, with $42 million of favorable prior period development versus $84 million in Q3 2025. The SG&A expense ratio fell to 14.0% from 17.5%. Net income attributable to Oscar Health was $167.3 million, or $0.49 per diluted share, versus a $137.5 million loss, or $(0.53) per share, in Q3 2025. On the outlook: Updated full year 2026 outlook: total revenue $19.0 billion to $19.3 billion (prior $18.7 billion to $19.0 billion); medical loss ratio 80.5% to 81.5% (prior 81.0% to 82.0%); SG&A expense ratio 15.1% to 15.6% (prior 15.6% to 16.1%); earnings from operations $850 million to $950 million (prior $600 million to $800 million). Figures are for Q3 2026, as Oscar Health Inc. Class A reported them.
- Revenue
- $5.1B
- Net Income
- $167M
- EPS
- $0.54
- Total Assets
- $10.0B
- Operating Cash Flow
- -$1.2B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $5.1B | $167M | $0.49 | 3.46% | -$1.2B |
| Q2 FY2026 | $4.9B | $362M | $1.10 | 7.85% | $2.0B |
| Q1 FY2026 | $4.6B | $679M | $2.07 | 15.15% | $2.6B |
| Q4 FY2025 | $2.8B | -$353M | -$1.24 | -11.9% | $663M |
| Q3 FY2025 | $3.0B | -$137M | -$0.53 | -4.33% | -$974M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $11.7B | -$443M | -$1.69 | -3.39% | $1.1B |
| FY2024 | $9.2B | $25M | $0.10 | 0.62% | $950M |
| FY2023 | $5.9B | -$271M | -$1.22 | -4.02% | -$298M |
Frequently asked questions
What was Oscar Health Inc. Class A's revenue last quarter?
Oscar Health Inc. Class A reported revenue of $5.14 billion for Q3 FY2026, up 72.1% from the same period a year earlier.
Is Oscar Health Inc. Class A profitable?
Yes. Oscar Health Inc. Class A reported net income of $167.3 million for Q3 FY2026, a net margin of 3.26% on revenue.
How has Oscar Health Inc. Class A's margin trended?
Operating margin was 3.46% in Q3 FY2026, compared with -4.33% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did Oscar Health Inc. Class A generate?
Oscar Health Inc. Class A generated free cash flow of -$1.21 billion in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Oscar Health, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.